Open AccessAdjuvant chemotherapy and overall survival in adult medulloblastoma
Author(s) -
Benjamin H. Kann,
N.H. Lester-Coll,
Henry S. Park,
D.N. Yeboa,
Jacqueline Kelly,
Joachim M. Baehring,
Kevin Becker,
James B. Yu,
Ranjit S. Bindra,
Kenneth B. Roberts
Publication year - 2016
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/now150
Subject(s) - medicine , proportional hazards model , propensity score matching , chemotherapy , adjuvant , survival analysis , radiation therapy , logistic regression , log rank test , oncology , surgery
Although chemotherapy is used routinely in pediatric medulloblastoma (MB) patients, its benefit for adult MB is unclear. We evaluated the survival impact of adjuvant chemotherapy in adult MB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom